Does Leucine Do More Than Build Muscle? New Mitochondrial Evidence on the Amino Acid's Role in Cellular Energy

What does the comparison between leucine's known and newly discovered roles look like?

Leucine is an essential branched-chain amino acid (BCAA) the human body cannot synthesize in sufficient quantities and must obtain through diet — and a landmark 2025 study published in Nature Cell Biology has revealed that its role extends far beyond protein synthesis and muscle repair into the direct regulation of mitochondrial energy output.

The finding, from Professor Dr. Thorsten Hoppe's laboratory at the University of Cologne's Institute for Genetics and CECAD Cluster of Excellence on Aging Research, centers on a previously unknown mechanism: leucine inhibits the degradation of outer mitochondrial membrane proteins, allowing mitochondria to respire more efficiently. This is not a marginal tweak to energy metabolism — it represents a direct, nutrient-sensing link between what you eat and how well your cells generate power.

Before diving into the mechanism, it helps to see how the old picture of leucine compares with what this research adds.

Role	Established Understanding	New Evidence (2025, Nature Cell Biology)
Muscle protein synthesis	Leucine activates mTORC1 signaling, stimulating anabolic pathways in skeletal muscle	Confirmed; this pathway remains intact and separate from the new mitochondrial mechanism
Mitochondrial function	Leucine supplementation augments specific mitochondrial respiratory pathways in older adults during rehabilitation	Leucine directly prevents degradation of outer mitochondrial membrane (OMM) proteins, boosting respiration at a molecular level
Energy production signal	Leucine was understood as a substrate for energy when oxidized	Leucine now shown to act as a nutrient signal that upregulates ATP production by modulating the quality-control protein SEL1L
Cancer cell metabolism	Limited direct data	Mutations affecting leucine metabolism enhance lung cancer cell survival — a new therapeutic consideration
Fertility	Not previously linked to leucine metabolism	Defects in leucine breakdown disrupt mitochondrial function and cause fertility problems in C. elegans
Quality-control balance	Not previously connected to leucine	Leucine downregulates SEL1L, reducing OMM protein clearance — but this same system prevents accumulation of damaged proteins

The 2025 findings do not replace the established science on leucine — they add an entirely new dimension to it.

What exactly did the University of Cologne researchers discover?

The study, titled "Leucine inhibits degradation of outer mitochondrial membrane proteins to adapt mitochondrial respiration", was led by first author Dr. Qiaochu Li and published in Nature Cell Biology (2025; 27(11): 1889). The core discovery is mechanistic: leucine stabilizes specific proteins on the outer surface of mitochondria by suppressing a cellular quality-control protein called SEL1L.

SEL1L is a component of the endoplasmic reticulum-associated degradation (ERAD) machinery that identifies damaged or misfolded proteins and routes them toward destruction. Under normal conditions, SEL1L performs an essential housekeeping function — clearing out defective proteins before they accumulate and cause harm. But the Cologne team found that SEL1L also acts on functional outer mitochondrial membrane (OMM) proteins, and that leucine availability modulates how aggressively SEL1L does this.

When leucine levels are high — as they would be after a protein-rich meal — SEL1L activity is reduced. Fewer OMM proteins are degraded. Those proteins, which include transporters that shuttle metabolic molecules into mitochondria, remain in place longer and in greater numbers. The result: mitochondria can function more efficiently, ultimately boosting the cell's energy production.

"We were thrilled to discover that a cell's nutrient status, especially its leucine levels, directly impacts energy production," said Dr. Li. "This mechanism enables cells to swiftly adapt to increased energy demands during periods of nutrient abundance."

Why does mitochondrial membrane protein stability matter so much?

To understand why this discovery is significant, it helps to appreciate what mitochondria actually do and why their outer membrane proteins are so critical.

Mitochondria produce adenosine triphosphate (ATP), the molecule that powers virtually every energy-requiring process in the body — from muscle contraction to nerve signaling to cell division. The adult human heart contains more than 2 billion muscle cells, each housing 5,000–8,000 mitochondria that work continuously to sustain cardiac function.

The outer mitochondrial membrane is not a passive boundary. It is studded with proteins that act as gatekeepers and transporters, controlling which molecules enter the mitochondria to be processed for energy. Premature degradation of these proteins reduces the mitochondria's import capacity, and energy production drops. Stabilize them, and mitochondria can import more substrate and generate more ATP.

This is precisely the lever leucine appears to pull. By dampening SEL1L-mediated degradation of OMM proteins, leucine keeps the mitochondrial import machinery better stocked during periods when nutrients — and therefore energy demand — are elevated. The cell uses leucine not just as a building block but as a real-time signal: nutrients are available, ramp up energy production.

How does this relate to leucine's established role in muscle and mTORC1 signaling?

The newly discovered mitochondrial pathway operates alongside — not instead of — leucine's well-characterized anabolic effects. Leucine is the most potent amino acid activator of mTORC1 (mechanistic target of rapamycin complex 1), a master regulator of cell growth and protein synthesis. When leucine enters a cell, it activates the Rag GTPase complex, which recruits mTORC1 to the lysosomal surface where it becomes active. mTORC1 then phosphorylates downstream targets including S6K1 and 4E-BP1, driving protein synthesis and muscle anabolism.

This pathway explains why leucine is the branched-chain amino acid most strongly associated with muscle protein synthesis, and why it is the active ingredient in most BCAA supplements marketed for muscle recovery. A review in Frontiers in Physiology (2023) confirmed that leucine stimulates protein synthesis by activating the mTORC1 signaling pathway and has demonstrated benefits for lipid metabolism and insulin sensitivity, making it a candidate for addressing metabolic diseases including type 2 diabetes and obesity.

The Cologne study adds a parallel track: leucine also signals through SEL1L to preserve mitochondrial infrastructure. These two pathways — mTORC1-mediated anabolism and SEL1L-mediated mitochondrial protection — likely work in concert during periods of dietary protein abundance, coordinating both the building of new cellular components and the energetic capacity to power that building process.

What did the research show in animal models and cancer cells?

The Cologne team extended their investigation beyond cell culture to two additional experimental systems, each revealing a different dimension of leucine's mitochondrial role.

Caenorhabditis elegans: Using this small roundworm — a standard model organism whose core cellular processes are conserved across species — the researchers studied what happens when leucine metabolism goes wrong. Defects in the breakdown of leucine disrupted mitochondrial function and were linked to fertility problems. This is a striking observation: it suggests that leucine metabolism is not just relevant to energy efficiency in well-nourished states, but is also essential for reproductive biology. Mitochondrial dysfunction in germ cells or reproductive tissues could impair fertility — a connection that warrants further investigation in mammalian models.

Human lung cancer cells: Certain mutations affecting leucine metabolism enhanced cancer cell survival. The finding cuts both ways. It suggests that leucine-related pathways are exploited by tumors to sustain their energy demands — a known vulnerability of cancer cells, which typically have elevated metabolic activity. It also raises a caution flag: any therapeutic strategy targeting leucine metabolism or SEL1L to boost energy production in healthy tissues would need to account for potential effects on tumor biology.

"Modulating leucine and SEL1L levels could be a strategy to boost energy production," said Dr. Li. "However, it is important to proceed with caution. SEL1L also matters for preventing the accumulation of damaged proteins, which is essential for long-term cellular health."

What does prior clinical research say about leucine and mitochondrial function?

The Cologne study is not the first to connect leucine with mitochondrial performance, but it is the first to identify a specific molecular mechanism. Earlier clinical work had already hinted at the connection.

A 2021 study published in the American Journal of Physiology examined healthy older adults (average age 69.1 years) who received leucine supplementation (0.06 g/kg body weight per meal) during 7 days of bed rest followed by 5 days of inpatient rehabilitation. Leucine supplementation increased ATP-linked respiration following rehabilitation (CON vs. LEU: −8.9 ± 6.2 vs. 15.5 ± 4.4 pmol O₂/s/mg tissue, P = 0.0042) and tended to preserve insulin sensitivity during bed rest. Leucine also reduced a marker of oxidative stress.

That study demonstrated a real-world, measurable effect of leucine on mitochondrial respiration in human muscle tissue — but could not explain the underlying mechanism. The Cologne team's discovery of the SEL1L pathway now provides a plausible molecular explanation for why leucine supplementation might improve mitochondrial respiratory capacity: by reducing OMM protein degradation, leucine keeps the mitochondrial import machinery functional even during periods of physical stress or reduced activity.

A broader review of leucine's metabolic roles, published in Amino Acids (2016), documented that leucine and its metabolites participate in both protein and energy metabolism, including roles in glucose homeostasis and lipid oxidation. The 2025 discovery builds on this foundation by identifying a specific, previously unknown arm of leucine's metabolic influence.

What are the potential therapeutic implications?

The discovery opens several avenues for future research and, eventually, clinical application — though significant caution is warranted before any of these translate to treatment.

Metabolic disorders: Conditions such as type 2 diabetes, obesity, and age-related metabolic decline are all characterized by impaired mitochondrial function. If leucine's SEL1L-mediated pathway can be harnessed to restore or enhance mitochondrial respiration, it could offer a dietary or pharmacological strategy for improving cellular energy metabolism. The University of Cologne team identified potential new therapeutic targets for diseases in which cellular energy production is disrupted, including cancer and metabolic disorders.

Cancer therapy: The observation that cancer cell mutations affecting leucine metabolism enhance tumor survival is clinically significant. Treatments that interfere with leucine uptake or its downstream signaling are already being explored in oncology. Understanding that leucine also stabilizes mitochondrial proteins — and that this stabilization can benefit cancer cells — adds complexity to the therapeutic picture. Targeting SEL1L in cancer cells might disrupt their mitochondrial stability and reduce their energy supply, but this would need careful validation.

Aging and sarcopenia: Mitochondrial dysfunction is a hallmark of cellular aging, and muscle loss (sarcopenia) in older adults is closely tied to both reduced protein intake and impaired mitochondrial function. Leucine supplementation is already used clinically to attenuate muscle loss in older adults. The new mechanism suggests that leucine's benefits in aging may extend beyond stimulating muscle protein synthesis to actively preserving mitochondrial infrastructure — a finding with direct relevance to healthy aging strategies.

Fertility: The C. elegans data linking leucine metabolism defects to fertility problems is preliminary but intriguing. If similar mechanisms operate in mammals, leucine adequacy could be relevant to reproductive health in ways not previously appreciated.

What are the limitations and unknowns?

The research is compelling, but several important caveats apply.

Much of the mechanistic work was conducted in cell culture and in C. elegans — a model organism with conserved but not identical biology to humans. The cancer cell observations were made in human lung cancer cell lines, which are useful but not the same as studying leucine metabolism in intact human tumors or healthy human tissue in vivo.

The SEL1L pathway is also a double-edged sword. SEL1L's primary job is to remove damaged proteins, and suppressing it — even partially — carries risk. If SEL1L activity is chronically reduced, misfolded or damaged proteins could accumulate, contributing to proteotoxic stress and diseases associated with protein aggregation. The researchers were explicit about this: boosting energy production by modulating SEL1L is a strategy that must be pursued carefully.

How much dietary leucine is needed to meaningfully activate this pathway in humans also remains open. Leucine is abundant in high-protein foods — dairy, meat, legumes — and most people eating adequate protein likely have sufficient leucine for normal cellular function. Whether supplemental leucine above dietary levels produces additional mitochondrial benefits in healthy individuals is not established by this research.

Finally, the interaction between leucine's mTORC1 pathway and its SEL1L pathway has not been fully mapped. It is not yet clear whether these pathways are independently regulated, whether they compete for leucine, or whether they are coordinated by a common upstream sensor.

What does this mean for how we think about dietary protein and cellular energy?

This research is part of a broader shift in nutritional science away from viewing food purely as fuel or raw material and toward understanding nutrients as active signaling molecules that shape how cells function.

In this new framework, leucine is not merely a substrate for protein synthesis. It is a bifunctional nutrient signal: one arm activates mTORC1 to drive anabolism, and the other suppresses SEL1L to preserve mitochondrial infrastructure and boost energy output. Both responses are appropriate to a state of nutrient abundance — when leucine is available, the cell simultaneously builds more protein and generates more energy to power that building.

The practical implications are real. Timing and composition of dietary protein — not just total caloric intake — can directly influence cellular energy metabolism at a mechanistic level. For populations with elevated energy demands (athletes, older adults recovering from illness or surgery, patients with metabolic disease), optimizing leucine intake may have benefits that extend well beyond muscle mass.

For those interested in the broader space of metabolic health, this finding connects to ongoing research into berberine for insulin resistance and other nutrient-based strategies for improving cellular energy handling. It also reinforces why protein quality — not just quantity — matters for metabolic outcomes.

The University of Cologne study was supported by Germany's Excellence Strategy through CECAD, the German Research Foundation (DFG) Collaborative Research Centres, the European Research Council's ERC Advanced Grant "Cellular Strategies of Protein Quality Control-Degradation" (CellularPQCD), and the Alexander von Humboldt Foundation. The full paper is available at DOI: 10.1038/s41556-025-01799-3.

Leucine's job description has just been significantly expanded. It is no longer accurate to describe it only as a muscle-building amino acid — it is now understood to be a direct regulator of mitochondrial energy production, one that works by protecting the very proteins that keep the cell's power plants running at full capacity.